Initial Versus Delayed PDT Combination With Conbercept in PCV

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Polypoidal Choroidal Vasculopathy
Interventions
DRUG

conbercept

At baseline conbercept injection is administered.And thereafter is administered based on re-treatment criteria from month 1 to 11.The PRN conbercept re-injection should be monthly.

PROCEDURE

Initial PDT

At baseline PDT with verteporfin is administered initially.And thereafter PDT is administered based on re-treatment criteria from month 3 to 11.The PRN PDT retreatment intervals should be no less than 3 months.

PROCEDURE

Delayed PDT

PDT is administered based on re-treatment criteria from month 3 to 11.The PRN PDT retreatment intervals should be no less than 3 months.

Trial Locations (3)

325000

The Eye Hospital of Wenzhou Medical University, Wenzhou

Unknown

The first affiliated hospital of Shanghai Jiaotong University, Shanghai

Sir Run Run Shaw Hospital, affiliated with the Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

The Eye Hospital of Wenzhou Medical University

OTHER

NCT02821520 - Initial Versus Delayed PDT Combination With Conbercept in PCV | Biotech Hunter | Biotech Hunter